Kathleen Moore to Quinolines
This is a "connection" page, showing publications Kathleen Moore has written about Quinolines.
Connection Strength
0.458
-
A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors. Clin Pharmacol Drug Dev. 2014 07; 3(4):284-9.
Score: 0.458